4D Molecular Therapeutics’ one-time gene therapy reduced the need for annual injections in patients with age-related blindness in a mid-stage trial.
The company on Wednesday …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
What You Should Know: – Samsung’s Galaxy Watch has received De Novo authorization from the US Food and Drug Administration (FDA) for its sleep apnea
What You Should Know: Sonio, a French medtech specializing in pregnant people and children’s health, is today finalizing a series A fundraising of $14 million
A new federal watchdog audit is ratcheting up pressure on government officials to crack down on billions of dollars in overcharges linked to Medicare Advantage